PFE congressional trades
Pfizer Inc. (PFE) appears in 32 congressional disclosure rows from 15 members of Congress in 2025–2026 periodic reports: 11 purchases and 21 sales, with trade dates from May 3, 2024 to Jun 8, 2026. Gilbert Cisneros reported the most, with 10 rows. The median gap between trade date and filing date is 28 days, and 5 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live PFE portfolio or a trading signal.
- 32
- 15
- 11 / 21
- $306K to $1.1M
- sum of reported ranges
- 2026-06-08
Verified PFE congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 11 purchases and 21 sales. Reported owners: Joint, Self, Spouse. Transaction dates run from 2024-05-03 to 2026-06-08.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Tommy Tuberville | Pfizer, Inc. Common Stock | Sale | Joint | $15,001 - $50,000 | #392ac3e5-07f6-4f8c-840f-84e9066ffb29 Filed 2026-07-16 | |
| Alan Armstrong | Pfizer, Inc. Common Stock | Sale | Self | $50,001 - $100,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20034285 Filed 2026-04-07 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20034144 Filed 2026-03-09 | |
| J. Hill | Pfizer, Inc. Common Stock | Sale | Self | $100,001 - $250,000 | #20033661 Filed 2026-01-23 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20031022 Filed 2025-09-12 | |
| Lisa McClain | Pfizer, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030932 Filed 2025-09-12 | |
| Lisa McClain | Pfizer, Inc. Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Julia Letlow | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Josh Gottheimer | Pfizer, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20030621 Filed 2025-07-16 | |
| Ron Wyden | Pfizer, Inc. Common Stock | Sale | Spouse | $1,001 - $15,000 | #fe7c39b7-a8ee-4011-b0f6-ab3a320546a0 Filed 2025-07-02 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030461 Filed 2025-06-06 | |
| Robert Bresnahan | Pfizer, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20030433 Filed 2025-05-31 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030288 Filed 2025-05-06 | |
| Bruce Westerman | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Jefferson Shreve | Pfizer, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20030231 Filed 2025-05-08 | |
| Robert Bresnahan | Pfizer, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20030238 Filed 2025-04-28 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Sale | Self | $15,001 - $50,000 | #20029026 Filed 2025-04-07 | |
| Carol Miller | Pfizer, Inc. Common Stock | Sale | Spouse | $15,001 - $50,000 | #20033779 Filed 2026-08-13 | |
| Carol Miller | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20029135 Filed 2025-04-11 | |
| Bruce Westerman | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Purchase | Self | $1,001 - $15,000 | #20027891 Filed 2025-03-06 | |
| Robert Bresnahan | Pfizer, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20029034 Filed 2025-03-27 | |
| Jefferson Shreve | Pfizer, Inc. Common Stock | Purchase | Self | $15,001 - $50,000 | #20027879 Filed 2025-03-09 | |
| John Boozman | Pfizer Inc | Sale | Joint | $1,001 - $15,000 | #b6f24083-8ed9-4368-b482-3d14155c1e9b Filed 2025-03-06 | |
| Julie Johnson | Pfizer, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20027936 Filed 2025-03-12 | |
| Gilbert Cisneros | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20026726 Filed 2025-02-11 | |
| Julie Johnson | Pfizer, Inc. Common Stock | Sale | Joint | $1,001 - $15,000 | #20026762 Filed 2025-02-12 | |
| Michael Rulli | Pfizer, Inc. Common Stock | Sale | Self | $1,001 - $15,000 | #20035147 Filed 2026-08-07 | |
| Tommy Tuberville | Pfizer, Inc. Common Stock | Sale | Joint | $15,001 - $50,000 | #0a25588d-a3f8-4ed6-971a-706097f78e3a Filed 2026-08-05 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
PFE disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Gilbert Cisneros's PFE trades | 10 | 5 | 5 | 2026-03-13 |
| Robert Bresnahan's PFE trades | 3 | 2 | 1 | 2025-05-15 |
| Bruce Westerman | 2 | 1 | 1 | 2025-04-21 |
| Carol Miller | 2 | 0 | 2 | 2025-03-10 |
| Jefferson Shreve | 2 | 1 | 1 | 2025-04-11 |
| Julie Johnson | 2 | 0 | 2 | 2025-02-12 |
| Lisa McClain | 2 | 1 | 1 | 2025-08-04 |
| Tommy Tuberville | 2 | 0 | 2 | 2026-06-08 |
| Alan Armstrong | 1 | 0 | 1 | 2026-03-24 |
| J. Hill | 1 | 0 | 1 | 2025-12-31 |
| John Boozman | 1 | 0 | 1 | 2025-02-13 |
| Josh Gottheimer | 1 | 0 | 1 | 2025-06-03 |
| Julia Letlow | 1 | 1 | 0 | 2025-06-17 |
| Michael Rulli | 1 | 0 | 1 | 2024-11-26 |
| Ron Wyden | 1 | 0 | 1 | 2025-06-03 |
How long disclosure took
Days from trade date to filing date for 32 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 5
- 16–30 days
- 16
- 31–45 days
- 6
- Over 45 days
- 5
- Median / longest
- 28d / 824d
Source documents
32 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #20033779Filed 2026-08-13 · 1 row
- #20035147Filed 2026-08-07 · 1 row
- #0a25588d-a3f8-4ed6-971a-706097f78e3aFiled 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #392ac3e5-07f6-4f8c-840f-84e9066ffb29Filed 2026-07-16 · 1 row
- #20034285Filed 2026-04-07 · 1 row
- #20034144Filed 2026-03-09 · 1 row
- #20033661Filed 2026-01-23 · 1 row
- #20030977Filed 2026-01-13 · 1 row
- #20033762Filed 2026-01-12 · 1 row
- #20033619Filed 2025-12-15 · 1 row
- #20030932Filed 2025-09-12 · 1 row
20 older filings are linked from the transaction table.
What PFE filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Pfizer Inc. financials and filings
Audited SEC figures, what moves PFE, and primary sources.
Compare LLY vs PFE side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
- Start here: how Yield Theory approaches research
Yield Theory is independent stock research for people investing their own money. Here is what's free, what members get, and three pieces to read first.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
PFE congressional trades: FAQ
Who in Congress traded PFE?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 32 verified PFE rows from 15 members: Alan Armstrong, Bruce Westerman, Carol Miller, Gilbert Cisneros, and 11 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current PFE holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are PFE amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $15,001 - $50,000; $50,001 - $100,000; $1,001 - $15,000; $100,001 - $250,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is PFE congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded PFE.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported PFE and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included